**Question:** Stability of the toxoid in snake's venom is due to

A. Enzymatic degradation inhibitors
B. High salt concentration
C. Acidic pH
D. Heat-resistant proteins

**Core Concept:** Snake venom contains various bioactive molecules, including toxins and enzymes, which can cause local or systemic effects in mammals. Toxoids are inactivated toxins prepared from venom, used as antigens for immunotherapy or research purposes. The stability of toxoids is crucial for their effectiveness and storage.

**Why the Correct Answer is Right:** The stability of toxoids in snake venom is mainly due to the presence of **enzymatic degradation inhibitors**. These inhibitors protect the toxoids from being broken down by enzymes, such as proteases, phospholipases, and hyaluronidases, which are abundant in venom. By inhibiting these enzymes, the toxoids remain intact and retain their antigenic properties, ensuring their effectiveness during immunotherapy or research purposes.

**Why Each Wrong Option is Incorrect:**

A. **Enzymatic degradation inhibitors** are present in snake venom, making this option incorrect. The stability of toxoids is primarily due to these inhibitors, not their absence.

B. **High salt concentration** does contribute to venom stability, but it is not the primary factor responsible for toxoid stability. Inhibitors play a more significant role in this context.

C. **Acidic pH** might influence venom stability, but the primary focus is on the enzymatic degradation inhibitors, which protect toxoids from enzymatic degradation.

D. **Heat-resistant proteins** are present in venom, but they are not the main reason for toxoid stability. Inhibitors play a more critical role in ensuring toxoid stability.

**Clinical Pearl:** Understanding the stability mechanisms of toxoids in snake venom is crucial for their utilization in immunotherapy and research applications. Enzymatic degradation inhibitors play a vital role in preserving the antigenic properties of toxoids, ensuring their effectiveness and long-lasting effects in the body after administration.